"Welcome to SSJ Finance"

Profit & Loss Accounts

Quarterly Results

Glenmark Pharmaceuticals Ltd
Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln	Chairman : Glenn Saldanha
Home : Indian Private	Book Value: 868.316327
BSE Code : 532296	Market Cap: 52638.92
NSE Code : GLENMARK	P / E : 28.09

Change Company :

Quarters:

(Rs in Cr.)

Quarterly Results

Particulars	Jun 2025	Mar 2025	Dec 2024	Sep 2024
Type	1Qtr	4Qtr	3Qtr	2Qtr
Net Sales	2178.90	1909.94	2208.84	2594.89
Other Income	69.34	88.45	129.19	83.08
Total Income	2464.26	2097.95	2380.47	2719.18
Total Expenditure	1990.00	1848.13	1757.35	1857.47
Operating Profit	474.26	249.81	623.12	861.70
Interest	15.46	13.13	8.46	11.80
Gross Profit	458.80	236.68	614.65	849.91
Depreciation	57.64	55.53	55.16	54.85
Tax	70.17	-25.62	95.26	138.46
Deferred Tax	0.77	59.02	50.43	61.54
Reported Profit After Tax	330.23	147.76	413.80	595.06

SSJ FINANCE & SECURITIES PRIVATE LIMITED:
1st Floor, Merchant Chamber, Opp. Patkar Hall, 41, New Marine Lines, Mumbai – 400 020
SEBI Regn. Number: INZ000178436 | CDSL: IN-DP-109-2015 | ARN: 40860 | CIN: U67120MH1996PTC104822

SSJ COMMODITIES PRIVATE LIMITED:
SEBI Regn. Number: INZ000013439 | CIN: U51909MH2003PTC140481|Research Analyst SEBI Reg. No.INH000001527

Content powered by Capital Market Charts are powered by TradingView